Sarepta Therapeutics Inc. (SRPT) Captures Spotlight with Post-Market Trading Surge
Sarepta Therapeutics Inc. (SRPT), a pioneer in precision genetic medicine targeting rare diseases, has experienced a surge in after-hours trading, signaling a wave of optimism within the biopharmaceutical industry. The company’s shares ended the day at a commendable $119.00, climbing by $3.36 per share. This jump reflects a 2.91% increase, suggesting that investors are resonating […]
